A team of researchers at ChristianaCare have identified a genetic signature that could help understand how colorectal cancer develops and predict survival rates in patients. From left: Lynn Opdenaker, Ph.D., Brian Osmond, Bruce Boman, M.D., Chi Zhang, Victoria Hunsu, Caroline Facey, Ph.D. Not pictured Pascal K. Kataboh, Ph.D.
ChristianaCare researchers identified a developmental genetic pattern that showed how colorectal cancer develops. The findings revealed that certain types of genes drive cancer growth and resistance, and how the precise timing of how they develop is linked to colon cancer formation.
The research team’s work also showed the genes can predict survival in colorectal cancer patients, indicating it can be a marker of disease behavior and a target for future therapies.
This week, Delaware Public Media’s Joe Irizarry sat down with Bruce Boman, M.D., senior author of the study and senior researcher at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute to discuss this colorectal cancer research.
Newly Identified HOX Gene
ChristianaCare's senior researcher, Bruce Boman, M.D., joined DPM's Joe Irizarry to explain how this new gene's identification will help them understand colorectal cancer.
Joe brings over 20 years of experience in news and radio to Delaware Public Media and the All Things Considered host position. He joined DPM in November 2019 as a reporter and fill-in ATC host after six years as a reporter and anchor at commercial radio stations in New Castle and Sussex Counties.
Colorectal cancer is one of the most lethal and prevalent forms of cancer. New research from ChristianaCare and the University of Delaware adds new data about how it forms and its early stages which could have long-term implications for treatment.To learn more, Delaware Public Media's Martin Matheny spoke to Dr. Bruce Boman, a senior researcher at the Cawley Center for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, who was one of the lead researchers.
Noting a sharp rise in colorectal cancer among younger people, the American Cancer Society now suggests that healthy adults get their first screening five years earlier — at age 45.
Colorectal cancer rates in adults over the age of 50 have been falling since the 1980s, but that’s not the case for young adults. New research shows that colorectal cancer incidences and deaths are increasing in people under 50.If that trend continues, colorectal cancer is expected to become the leading cause of cancer-related deaths among young adults globally by 2030.Delaware Public Media’s Kyle McKinnon sits down with Bayhealth colorectal surgeon Dr. Assar Rather to examine the rise in colorectal cancer for young people and how it’s being addressed.